. . . . . . . . . "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "Cot/+Wg+yTn4tsiaBrFKeqdw/FvGPJuA5IAz5Z4Eoq8J1dCGnf9UJ9BF9UgzD11YNGqDwepkIVPc/T53Uvt70zmFDHo6bIgJIb8jT0BBQT0pR216JrYZ82kENgUrt3MbLr+AYqzf5KzvFSElgIDKy0W0HLMghBLQgmng2OJ6yhY=" . . "2021-04-03T11:49:31.054+02:00"^^ . . . . .